Work

PAK1‐mediated HDAC1 phosphorylation promotes prostatic stromal fibrosis through SP1‐dependent TGF‐β1 transcription in benign prostatic hyperplasia

Year: 2026
Type: article
Abstract: Prostatic fibrosis is an important contributor to the progression and clinical manifestations of benign prostatic hyperplasia (BPH), whereas the underlying molecular mechanisms remain incompletely understood. In this study, integrative multi‐omics analyses, including RNA sequencing, proteomics, and phosphoproteomics, identified p21‐activated kinase 1 (PAK1) as a key regulator associated with prostatic fibrosis. PAK1 expression was markedly increased and was closely associated with the progression of prostatic fibrosis and BPH. Transcriptomic analyses further indicated that the profibrotic effects of PAK1 were closely related to activation of the TGF‐β signaling pathway. Functional experiments demonstrated that PAK1 promoted fibrosis‐related phenotypes and enhanced TGF‐β1 expression. Mechanistically, PAK1‐induced phosphorylation of histone deacetylase 1 (HDAC1) was associated with reduced SP1 acetylation and enhanced SP1‐dependent transcriptional activity, thereby facilitating TGF‐β1 transcription. In vivo, both genetic silencing of PAK1 and pharmacological inhibition with IPA‐3 alleviated prostatic fibrosis and attenuated BPH‐associated pathological changes. Collectively, these findings support a model in which PAK1 contributes to prostatic fibrosis and BPH progression through modulation of the HDAC1/SP1/TGF‐β1 signaling axis and suggest that PAK1 may represent a potential therapeutic target for BPH.
Source: View
Language: English
Subfield: Urology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W7234188424
FWCI:
Cites: 45
Cited by:
Related to: 10